Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States.

Atkins CY, Patel A, Taylor TH Jr, Biggerstaff M, Merlin TL, Dulin SM, Erickson BA, Borse RH, Hunkler R, Meltzer MI.

Emerg Infect Dis. 2011 Sep;17(9):1591-8. doi: 10.3201/eid1709.110295.

2.

Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).

Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, Owusu-Edusei K, Bell B, Mead PS, Biggerstaff M, Brammer L, Davidson H, Jernigan D, Jhung MA, Kamimoto LA, Merlin TL, Nowell M, Redd SC, Reed C, Schuchat A, Meltzer MI.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S75-82. doi: 10.1093/cid/ciq012.

PMID:
21342903
3.

Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment.

Hernandez JE, Grainger J, Simonsen L, Collis P, Edelman L, Sheridan WP.

Influenza Other Respir Viruses. 2012 Sep;6(5):305-8. doi: 10.1111/j.1750-2659.2011.00303.x. Epub 2011 Nov 16.

4.

Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.

Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, Gershman K, Yousey-Hindes K, Arnold K, Ryan P, Lynfield R, Morin C, Baumbach J, Hancock EB, Bennett NM, Zansky S, Thomas A, Schaffner W, Fry AM.

J Infect Dis. 2011 Dec 15;204(12):1848-56. doi: 10.1093/infdis/jir648. Epub 2011 Oct 19.

PMID:
22013219
5.

Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.

Ujike M, Ejima M, Anraku A, Shimabukuro K, Obuchi M, Kishida N, Hong X, Takashita E, Fujisaki S, Yamashita K, Horikawa H, Kato Y, Oguchi A, Fujita N, Tashiro M, Odagiri T; Influenza Virus Surveillance Group of Japan.

Emerg Infect Dis. 2011 Mar;17(3):470-9. doi: 10.3201/eid1703.101188.

6.

Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM; US Antiviral Resistance Surveillance Working Group.

Emerg Infect Dis. 2012 Feb;18(2):308-11. doi: 10.3201/eid1802.111466.

7.

Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.

Higuera Iglesias AL, Kudo K, Manabe T, Corcho Berdugo AE, Corrales Baeza A, Alfaro Ramos L, Guevara Gutiérrez R, Manjarrez Zavala ME, Takasaki J, Izumi S, Bautista E, Perez Padilla JR.

PLoS One. 2011;6(7):e21838. doi: 10.1371/journal.pone.0021838. Epub 2011 Jul 8.

8.

U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.

Borders-Hemphill V, Mosholder A.

Influenza Other Respir Viruses. 2012 Nov;6(6):e129-33. doi: 10.1111/j.1750-2659.2012.00384.x. Epub 2012 Jun 9.

9.

Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Jan 8;58(51):1436-40.

10.

Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States.

Graitcer SB, Gubareva L, Kamimoto L, Doshi S, Vandermeer M, Louie J, Waters C, Moore Z, Sleeman K, Okomo-Adhiambo M, Marshall SA, St George K, Pan CY, LaPlante JM, Klimov A, Fry AM.

Emerg Infect Dis. 2011 Feb;17(2):255-7. doi: 10.3201/eid1702.101724.

11.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M.

Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13.

PMID:
21767571
12.

Prescribing in a pandemic: best use of oseltamivir in paediatric intensive care.

Seale AC, Toussaint FS, Finn A, Fraser JI.

Arch Dis Child. 2011 Sep;96(9):902-3. doi: 10.1136/adc.2010.183806. Epub 2010 Aug 10. No abstract available.

PMID:
20702390
13.

Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.

Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA.

Influenza Other Respir Viruses. 2012 Nov;6(6):e143-51. doi: 10.1111/j.1750-2659.2012.00390.x. Epub 2012 Jun 11.

14.

Pandemic influenza A (H1N1) 2009: risk factors for hospitalization.

Lenzi L, Mello ÂM, Silva LR, Grochocki MH, Pontarolo R.

J Bras Pneumol. 2012 Jan-Feb;38(1):57-65. English, Portuguese.

15.

Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.

Kawai N, Ikematsu H, Tanaka O, Matsuura S, Maeda T, Yamauchi S, Hirotsu N, Nishimura M, Iwaki N, Kashiwagi S.

J Infect Chemother. 2011 Jun;17(3):375-81. doi: 10.1007/s10156-010-0179-9. Epub 2010 Dec 1.

PMID:
21120678
16.

Influenza-associated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1) virus--United States, 2009.

Jain S, Benoit SR, Skarbinski J, Bramley AM, Finelli L; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team.

Clin Infect Dis. 2012 May;54(9):1221-9. doi: 10.1093/cid/cis197. Epub 2012 Mar 20.

PMID:
22437239
17.

Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan.

Chuang JH, Huang AS, Huang WT, Liu MT, Chou JH, Chang FY, Chiu WT.

PLoS One. 2012;7(4):e36120. doi: 10.1371/journal.pone.0036120. Epub 2012 Apr 24.

18.

Burden of severe 2009 pandemic influenza A (H1N1) infection in children in Southeast Spain.

Moral L, Marco N, Toral T, Fuentes MJ, Fuentes L, Lillo L.

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):497-501. doi: 10.1016/j.eimc.2011.01.015. Epub 2011 Apr 21.

PMID:
21514011
19.

Approach to Pandemic 2009 influenza: first report from a main referral hospital for Pandemic H1N1 influenza care in Iran.

Dashti-Khavidaki S, Khalili H, Gholamalipour F, Soudbakhsh A, Talasaz AH, Hajabdolbaghi M, Rasoolinejad M, Mokhtari Azad T, Fathi M, Talebian MT, Nasiripour S.

J Infect Dev Ctries. 2010 Oct 28;4(10):629-35.

20.

Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010.

Calatayud L, Lackenby A, Reynolds A, McMenamin J, Phin NF, Zambon M, Pebody R.

Emerg Infect Dis. 2011 Oct;17(10):1807-15. doi: 10.3201/eid1710.110117.

Supplemental Content

Support Center